Medicare will start covering obesity drugs for the first time. Here's what patients should know

Starting tomorrow, Medicare will cover obesity drugs for the first time. According to CNBC, the move unlocks access to medications from Novo Nordisk and Eli Lilly for millions of seniors who previously couldn't afford them. It's a major expansion for patients seeking treatment and a major win for pharmaceutical companies expecting significant sales growth.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton